Issue

  • Issue: 
    8

    August, 2005

    Dear Readers,

    In this month’s Evidence Corner, Dr. Laura Bolton reviews and includes commentary on 2 very interesting studies on the effects of sharp debridement. In her introduction to the article, she defines a distinction between the 2 terms, sharp debridement and surgical debridement. Bolton’s summaries of the published articles entitled “Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: a concurrently controlled, prospective cohort study” (Williams et al.) and “Effect of extensive debridement and treatment on

  • Issue: 
    8

    Sharp Debridement Aids Recalcitrant Venous Ulcer Healing

    Reference: Williams D, Enoch S, Miller D, Harris K, Price P, Harding KG. Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: a concurrently controlled, prospective cohort study. Wound Repair Regen. 2005;13(2):131–137.
    Rationale: Chronic nonhealing venous leg ulcer (CVLU) wound beds usually contain slough and nonviable tissue. It is common practice to remove devitalized tissue using autolytic, enzymatic, mechanical, biosurgical, surgical, or sharp debridement, with the latter 2 dee

  • Issue: 
    8

    Acknowledgment: This study was funded in part by HSR&D, Nursing Research Initiative, Department of Veteran’s Affairs (NRI 1-005-01), Washington, DC, and National Institutes of Health, National Institute of Nursing Research (NINR RO1 NR07721), Bethesda, Md.

  • Issue: 
    8

    F ree flap reconstruction is a well established technique for the closure of large, complex wounds of the extremities with exposed functional structures.1 The management of wounds in which there are large areas of exposed bone or tendons or in wounds that are located in functionally active areas can become a formidable task when free flap coverage is contraindicated. Such circumstances include extensive crush or burn injuries in which the condition of the recipient vessels eliminates free tissue transfer as an option. Other situations that may necessitate an alternative to free fla

  • Issue: 
    8

    A ppropriate wound management is a major issue in hospital care involving almost all fields of medical care. Despite the prophylactic use of a variety of clinically efficient antibiotics in many surgical procedures, the concomitant use of local antiseptics still represents a common and useful therapeutic measure to control wound infection. Particularly for immunocompromised patients, topical antiseptics have to be safe, ie, they must not impair the physiological wound healing process. However, recent publications1–4 reported various interactions of commonly used local antiseptics

  • Issue: 
    8

    C ritical colonization and infection of wounds present a dual problem for clinicians. First, there is the possibility of delayed wound healing, particularly in the presence of a compromised immune system or where the wound is grossly contaminated or poorly perfused.1 Second, colonized and infected wounds are a potential source for cross-infection—a particular concern as the spread of antibiotic-resistant species continues. For patients, an infected wound can have additional consequences including increased pain and discomfort, a delay in return to normal activities, and the possi

  • Issue: 
    8

    A 54-year-old man was involved in a motor vehicle crash as the driver of a motorcycle. No significant medical history was noted prior to the accident. He sustained no damage to his vital organs, spine, or head. He sustained an open right ankle crush fracture, which transected his right posterior tibial artery. Six days after admission to a tertiary hospital, after 2 surgical attempts at limb salvage and 17 units of packed cells, a below-the-knee amputation (BKA) was performed.
    Five days postamputation, the patient was transferred to a local transitional care unit for reconditioning and man

  • Issue: 
    8

    TheWoundInstitute.comSM Receives Prestigious IN-AWE Silver Award from Medical Marketing Association

    Healthpoint (Fort Worth, Tex) announces that TheWoundInstitute.com, an online source for accredited wound care education, received the IN-AWE International Awards of Excellence Medical Education CE/CME Silver Award at the Medical Marketing Association (MMA) Annual Meeting held June 9, 2005, in Los Angeles, Calif.
    Every year, the MMA recognizes outstanding performances related to medical or healthcare marketing for professional, trade, or consumer audiences at their annual national conferen

Ostomy Wound Management

Press Release

ConvaTec and Boehringer Technologies Announce License Agreement


ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System

SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.


WOUNDS News Wire

CME Showcase

"Diabetic Peripheral Neuropathy"

Upcoming Accredited Webcast

Release Date: December 22, 2008

Expiration Date: December 22, 2009

This activity is supported by an educational grant from PamLabs.
This activity is sponsored by the North American Center For Continuing Medical Education (NACCME).

To register for this Webcast, visit www.naccme.com/program/n-558/


"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"

Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009

Rebroadcasts

7:30-8:30 p.m. EDT
January 27, 2009

3-4 p.m. EDT
January 28, 2009

This activity is supported by an educational grant from Advanced Biohealing.
This activity is sponsored by the North American Center For Continuing Medical Education (NACCME).

To register for this Webcast, visit www.naccme.com/program/n-550/


MRSA And Diabetic Foot Wounds: Where Do We Go From Here?
Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME).

 

PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies
Archived Accredited Webcast with Q&A:
This activity is supported by an educational grant from Baxter Healthcare Corporation.


Maintenance Debridement: A New Look at Science and Art
Accredited Webcast with Q&A:
November 17, 2008 at 3:00pm EST
This activity is supported by an educational grant from HealthPoint Ltd.
 

REVIEW OUR OTHER
WOUND CARE BRANDS

Check out our other resources for healthcare professionals of all specialties.

  • Ostomy Wound Management
  • Todays Wound Clinic
  • Podiatry Today
  • Skin and Aging